-
Tofacitnib Citrate
API lub npe Qhov taw qhia Specification US DMF EU DMF CEP Tofacitnib Citrate Rheumatoid mob caj dab Hauv tsev -
Sugammadex Sodium
API lub npe Qhov taw qhia Specification US DMF EU DMF CEP Sugammadex Sodium Neuromuscular thaiv Hauv tsev -
Sacubitril Hemicalcium hmoov
API lub npe Qhov taw qhia Specification US DMF EU DMF CEP Sacubitril Hemicalcium hmoov Hauv tsev -
Sofosbuvir
API lub npe Qhov taw qhia Specification US DMF EU DMF CEP Sofosbuvir HCV Hauv tsev ib 32048 √ -
Ribociclib 1374639-75-4
API lub npe Qhov taw qhia Innovator Patent Expiry Date (Tebchaws Asmeskas) Ribociclib 1374639-75-4 HR-positive, HER2-negative Andvance ormetastaticbreast Cancers Novartis
PharmaceuticalsPeb Hlis 27, 2028 -
Rivaroxaban
API lub npe Qhov taw qhia Specification US DMF EU DMF CEP Rivaroxaban Anticoagulant Hauv tsev TDP -
Rosuvastatin Calcium
API lub npe Qhov taw qhia Specification US DMF EU DMF CEP Rosuvastatin Calcium Hypercholesterolemia Hauv Tsev / CEP 20705 ib √ PEB 2015-240 -
Pitavastatin Calcium
API lub npe Qhov taw qhia Specification US DMF EU DMF CEP Pitavastatin Calcium Hypercholesterolemia Hauv tsev -
Pregabalin
API lub npe Qhov taw qhia Specification US DMF EU DMF CEP Pregabalin Epilepsy / Neuralgia Hauv Tsev / EP 22223 ib √ PEB 2016-141 -
Obeticholic Acid
API lub npe Qhov taw qhia Specification US DMF EU DMF CEP Obeticholic Acid Cov kab mob biliary cholangitis Hauv tsev -
Ib 1038915-60-4
API lub npe Qhov taw qhia Innovator Patent Expiry Date (Tebchaws Asmeskas) Ib 1038915-60-4 Ovarian/Fallopian, tube/primary peritoneal cancer Tesaro Peb Hlis 8, 2028 -
Ledipasvir Actone / PVP
API lub npe Qhov taw qhia Specification US DMF EU DMF CEP Ledipasvir Actone / PVP HCV Hauv tsev √
